Clinical Trials Logo

Clinical Trial Summary

This study consists 2 phases. The first phase will conduct a cross-sectional study to determine the infection rate of Toxocariasis larvae, describe the clinical and paraclinical characteristics, identify risk factors related to Toxocariasis larva infection. The second phase will conduct an interventional study to evaluate the effectiveness and factors related to the Albendazole treatment on pupils infected with Toxocariasis larvae in Ho Chi Minh City.


Clinical Trial Description

This study includes 2 phases below: Phase 1: Cross-sectional study Sample population: total 960 pupils aged 3-15 years old from public kindergartens, primary schools, and secondary schools in Ho Chi Minh City. Data collection will be conducted following stages below: 1. Explain counseling to parents/guardians and explain to children (for children > 9 years old) about Toxocariasis in dogs/cats, procedures for examination, testing, medication and follow-up. Clearly explain the benefits as well as the possible risks of participating in the study. If agreeing to participate, the parent/guardian and the child (over 9 years old) sign the commitment through a consent form. 2. Clinical examination by doctors of Pediatrics, Pham Ngoc Thach University of Medicine, seniority, prestige, practice certificates, undergraduate and postgraduate teaching at the hospital Children 2. 3. Fill in the data collection questionnaire 4. Taking blood for testing: - Type of test: Complete blood count (TPTTBM), AST, ALT, Urea, Creatinine, IgE, ELISA. - Place of implementation: At the school of the child selected for the study. - Performer: Senior and skilled pediatric nurse working at Children's Hospital 2, with good practice and professional certificates - Blood volume taken: 4ml (0.5ml for BM; 1.5ml for urea, creatinine, AST, ALT, IgE; 2ml for ELISA). - Preserve and transport blood samples to the laboratory of Children's Hospital 2 according to the procedure. - Treatment of accidents, if any, during the procedure: Equip shock-proof boxes and appropriate on-site first aid tools, treat them according to the protocol of the Ministry of Health, transfer the child to the nearest medical facility. 5. Make an appointment to announce test results and re-evaluate. 6. Nurturing children Phase 2: Interventional study Children infected with Toxocariasis larvae were recruited from the cross-sectional survey based on the results of positive ELISA test for Toxocariasis, with or without increased BCAT and IgE, history and clinical symptoms. Sample size was calculated based on the research results of Fernando (treatment within 3 months), about 146 children will be recruited about 146 children, intervention with Albendazole treatment on these children is sufficient. Evaluation after intervention: Children after being diagnosed will be invited into intervention with Albendazole according to the protocol, continued to follow up after 1 month and 6 months in most cases. * Within the scope of this topic, we evaluate the cure based on standards from the disease under the guidance of the Vietnam Ministry of Health in 2020 - Clinical symptoms decrease or disappear after treatment - The ELISA test has decreased or returned negative antibody titers. - The percentage of eosinophils, total IgE decreased or returned to normal values. Data collection process includes the steps of intervention by the research team below: 1. Inform parents/guardians and children (over 9 years old) of their child's infection with toxocariasis and counseling to participate in treatment. 2. Counseling to participate in the treatment course: Explain clearly the intervention process, the benefits and possible side effects when participating in the treatment course. If they agree, the parent/guardian and the child (over 9 years old) will sign a consent form to participate in phase 2. 3. Distribute albedazol (Zentel) 200mg at school to guardians, dose 15mg/kg divided into 2 times/day, guide to take the medicine in full dose, at the right time after eating, taking full day 5 4. Advice on prevention of reinfection: feeding children cooked food, deworming dogs, handling dog feces, washing hands when touching soil, washing hands before eating, do not hold dogs/cats.... 5. Instruct family members to monitor unwanted effects of albedazol (abdominal pain, nausea, urticaria, itching, allergic reactions...), if any, contact the research team's phone number for guidance and treatment according to the guidance of the Ministry of Health. 6. Schedule a follow-up visit after 1 month, clinical assessment. 7. Control medication compliance: daily, the research team will call parents to remind them to take the medicine, put the pill pack in the child's school bag to send back to the medical control agency. , and ask about the side effects of the drug or not. 8. Schedule a follow-up visit after 6 months from taking the drug, clinical assessment, blood collection as in the process of stage 1, repeat TPM, AST, ALT, Urea, Creatinine, IgE, ELISA. , 9. Nurturing children. In case of suspected heart, lung, liver, eye damage, etc., we will refer you to Children's Hospital 2 for examination by specialty and not for intervention. Standard operating procedures Examination procedure The research team coordinated with the school administration and the school health department to organize a visit at the school. Examination of children is carried out by pediatricians of Pham Ngoc Thach University of Medicine with seniority, prestige, and practice certificates, undergraduate and postgraduate teaching jobs at Children's Hospital 2. Procedures for taking blood samples, storing and transporting samples and handling accidents Sample Place of implementation: At the school of the child selected for the study. Test type: Complete blood count (TPTTBM), AST-ALT, Urea Creatinine, IgE, ELISA Performer: Pediatric nurse with seniority working at Children's Hospital 2, with good practice and professional certificates. Blood volume: 4ml (divided into 3 specialized tubes: 0.5ml for BM; 1.5ml for urea-creatinine, AST-ALT, IgE; 2ml for ELISA) Storage and transportation Blood samples are stored at 4 - 8ºC in a dedicated shipping container and transported to Children's Hospital 2 laboratory 2 hours before the time of sampling according to the correct procedure Handling accidents Equip shockproof box and appropriate on-site first aid equipment, handle according to the protocol of the Ministry of Health, transfer the child to the nearest medical facility. Procedure for performing the test Place of implementation: Laboratory of Children's Hospital 2 (hematology, biochemistry, microbiological diagnosis) Technique of ELISA test to find antibodies to Toxocariasis larvae. Test principles - Microwells are coated with exocrine antigens of Toxocara larvae. During the first incubation with the patient's diluent serum, if any antibodies react with the antigen, they will bind to the antigen-coated wells. After washing off the remainder of the sample, add the conjugate enzyme. - During the second incubation, the conjugate enzyme will bind to any antibodies present. After a second wash, a coloring agent (tetramethylbenzidine or TMB) is added. In the presence of the conjugate enzyme, peroxidase catalyzes the use of peroxide to turn the colorant blue. The blue color turns yellow after the addition of the stopping solution. Results are read visually or using an ELISA reader. Sample collection and preparation Serum or plasma is stored at 2-8 0C for five days. Serum can be kept longer if stored at -20ºC for a long time. Do not freeze whole blood samples. Do not heat the sample and avoid freezing and thawing many times. Read the results ELISA reader: reads zero with air. Set up a dual wavelength readout at 450/620-650 nm. Positive: Absorbance reading is more than 0.3 OD units. Negative: Absorbance reading is less than 0.3 OD units. Information of the Toxocara ELISA Kit used for testing - Test Toxocara IgG ELISA - Kit name AccuDiag™ Toxocara IgG ELISA Kit - Country of manufacture: America - Method Enzyme-linked immunosorbent - Skill Sandwich complex - Detection threshold Qualifying: positive or negative - Sample 5 L serum/plasma - Test time ~ 20 minutes - Expiry date 12 months from date of manufacture - Specificity 93.3% - Sensitivity 87.5% - Circulation license number Number: 8362NK/BYT-TB-CT, March 9, 2018 of the Ministry of Health Procedure for monitoring and taking care of children during treatment During the time the intervention group takes albedazol, the research team will coordinate with the school health department to monitor the children's clinical manifestations, call parents and guardians to assess unwanted effects of medication, reminders of treatment adherence, and preventive measures. Procedure for recording side effects, adverse events, and adverse event handling - Instruct family members to monitor unwanted effects of albedazol (abdominal pain, nausea, urticaria, itching, allergic reactions...), if any, contact the research team's phone number for advice. advice and guidance. - Depending on the severity of the reaction, the research team will advise monitoring if the reaction is mild, or guide hospitalization for treatment and management according to the guidance of the Ministry of Health if the reaction is severe (Appendix 4). When determining that this reaction is caused by albedazol, the child's treatment costs will be covered from the project's funding (Section 11 Appendix 8) - Record unwanted effects according to the ADR report form (Appendix 6) and send information to the National Center for Drug Information and Adverse Drug Reaction Monitoring (Hanoi University of Pharmacy:13- 15 Le Thanh Tong, Hoan Kiem District, Hanoi, email: [email protected] ). Ethics This study was carried out through clinical examination, blood collection for routine tests and oral Albedazol intervention. We only conduct tests and drug interventions with the consent of the family and the school (signed the agreement through the consent form). During the research, children are always monitored and evaluated for complications as well as side effects of drugs; If any, they will be consulted or treated according to the guidance of the Ministry of Health and the treatment costs will be covered from the project's budget. This study was conducted with the approval of the Biomedical Research Ethics Council of Pham Ngoc Thach University of Medicine Ho Chi Minh City. Funding: Department of Science and Technology of Ho Chi Minh City, Vietnam. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05208333
Study type Interventional
Source Pham Ngoc Thach University of Medicine
Contact Lan Anh T Do, PhD
Phone +84945217146
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date May 2022
Completion date March 2024